SkinHealth Systems (SKIN) Liabilities and Shareholders Equity (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $473.2 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 29.77% year-over-year to $473.2 million in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 28.39% decrease from a year earlier, with the FY2025 full-year figure at $499.8 million, down 27.11% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $473.2 million, down from $499.8 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for SKIN reached as high as $1.2 billion in Q2 2022 and fell as low as $473.2 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $825.1 million across 5 years, with a median of $844.7 million in 2024.
• Across the five-year window, Liabilities and Shareholders Equity soared 254.72% in 2022 and slipped 29.77% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $1.0 billion in 2022, then decreased by 7.37% to $929.1 million in 2023, then decreased by 26.2% to $685.7 million in 2024, then decreased by 27.11% to $499.8 million in 2025, then slipped by 5.32% to $473.2 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $473.2 million in Q1 2026, $499.8 million in Q4 2025, and $503.6 million in Q3 2025.